- Home
- CMPX vs NEWP Comparison
CMPX vs NEWP Comparison
Compare CMPX & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- NEWP
- Stock Information
- Founded
- CMPX 2014
- NEWP 1972
- Country
- CMPX United States
- NEWP Canada
- Employees
- CMPX N/A
- NEWP N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- NEWP
- Sector
- CMPX Health Care
- NEWP
- Exchange
- CMPX Nasdaq
- NEWP Nasdaq
- Market Cap
- CMPX 229.5M
- NEWP 223.1M
- IPO Year
- CMPX N/A
- NEWP N/A
- Fundamental
- Price
- CMPX $1.75
- NEWP $1.17
- Analyst Decision
- CMPX Strong Buy
- NEWP Strong Buy
- Analyst Count
- CMPX 8
- NEWP 1
- Target Price
- CMPX $13.38
- NEWP $5.00
- AVG Volume (30 Days)
- CMPX 2.8M
- NEWP 342.7K
- Earning Date
- CMPX 05-12-2025
- NEWP 05-06-2025
- Dividend Yield
- CMPX N/A
- NEWP N/A
- EPS Growth
- CMPX N/A
- NEWP N/A
- EPS
- CMPX N/A
- NEWP N/A
- Revenue
- CMPX $850,000.00
- NEWP N/A
- Revenue This Year
- CMPX $47.65
- NEWP N/A
- Revenue Next Year
- CMPX $2,767.57
- NEWP N/A
- P/E Ratio
- CMPX N/A
- NEWP N/A
- Revenue Growth
- CMPX N/A
- NEWP N/A
- 52 Week Low
- CMPX $0.77
- NEWP $0.93
- 52 Week High
- CMPX $4.08
- NEWP $2.53
- Technical
- Relative Strength Index (RSI)
- CMPX 41.42
- NEWP 52.69
- Support Level
- CMPX $1.60
- NEWP $1.09
- Resistance Level
- CMPX $1.78
- NEWP $1.24
- Average True Range (ATR)
- CMPX 0.27
- NEWP 0.08
- MACD
- CMPX 0.03
- NEWP 0.01
- Stochastic Oscillator
- CMPX 38.01
- NEWP 77.42
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About NEWP New Pacific Metals Corp.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.